{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:12:29Z","timestamp":1788567149079,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41401-026-01793-x","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T14:29:34Z","timestamp":1778164174000},"page":"2554-2568","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CYFIP2 deficiency ameliorates renal interstitial fibrosis through attenuating tubular senescence in hypertensive nephropathy"],"prefix":"10.1038","volume":"47","author":[{"given":"Ming-chen","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-wen","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-zhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-li","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-shen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-bo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-ran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui-cui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-wu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"1793_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41569-021-00559-8","volume":"18","author":"B Zhou","year":"2021","unstructured":"Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021;18:785\u2013802.","journal-title":"Nat Rev Cardiol"},{"key":"1793_CR2","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41581-022-00616-6","volume":"18","author":"K Matsushita","year":"2022","unstructured":"Matsushita K, Ballew SH, Wang AYM, Kalyesubula R, Schaeffner E, Agarwal R. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol. 2022;18:696\u2013707.","journal-title":"Nat Rev Nephrol"},{"key":"1793_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11906-020-01091-9","volume":"22","author":"F Elijovich","year":"2020","unstructured":"Elijovich F, Laffer CL, Sahinoz M, Pitzer A, Ferguson JF, Kirabo A. The gut microbiome, inflammation, and salt-sensitive hypertension. Curr Hypertens Rep. 2020;22:79.","journal-title":"Curr Hypertens Rep"},{"key":"1793_CR4","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/ndt\/gfr402","volume":"27","author":"MCJ Slagman","year":"2012","unstructured":"Slagman MCJ, Kwakernaak AJ, Yazdani S, Laverman GD, Van Den Born J, Titze J, et al. Vascular endothelial growth factor c levels are modulated by dietary salt intake in proteinuric chronic kidney disease patients and in healthy subjects. Nephrol Dialysis Transplant. 2012;27:978\u201382.","journal-title":"Nephrol Dialysis Transplant"},{"key":"1793_CR5","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/HYPERTENSIONAHA.123.21369","volume":"81","author":"M Nishimoto","year":"2024","unstructured":"Nishimoto M, Griffin KA, Wynne BM, Fujita T. Salt-sensitive hypertension and the kidney. Hypertension. 2024;81:1206\u201317.","journal-title":"Hypertension"},{"key":"1793_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.freeradbiomed.2022.10.320","volume":"193","author":"XT Li","year":"2022","unstructured":"Li XT, Song JW, Zhang ZZ, Zhang MW, Liang LR, Miao R, et al. Sirtuin 7 mitigates renal ferroptosis, fibrosis and injury in hypertensive mice by facilitating the KLF15\/Nrf2 signalling. Free Radic Biol Med. 2022;193:459\u201373.","journal-title":"Free Radic Biol Med"},{"key":"1793_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63152-4","volume":"16","author":"L Huang","year":"2025","unstructured":"Huang L, Shen Y, Pan X, Li J, Li C, Ruan L, et al. Noncanonical function of pannexin1 promotes cellular senescence and renal fibrosis post-acute kidney injury. Nat Commun. 2025;16:7699.","journal-title":"Nat Commun"},{"key":"1793_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14184","volume":"23","author":"S Ha","year":"2024","unstructured":"Ha S, Kim HW, Kim KM, Kim BM, Kim J, Son M, et al. PAR2-mediated cellular senescence promotes inflammation and fibrosis in aging and chronic kidney disease. Aging Cell. 2024;23:e14184.","journal-title":"Aging Cell"},{"key":"1793_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28096-z","volume":"13","author":"Q Yuan","year":"2022","unstructured":"Yuan Q, Ren Q, Li L, Tan H, Lu M, Tian Y, et al. A Klotho-derived peptide protects against kidney fibrosis by targeting TGF-\u03b2 signalling. Nat Commun. 2022;13:438.","journal-title":"Nat Commun"},{"key":"1793_CR10","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41401-023-01216-1","volume":"45","author":"M Yang","year":"2024","unstructured":"Yang M, Liu Y, Luo S, Liu C, Jiang N, Li C, et al. DsbA-L ameliorates renal aging and renal fibrosis by maintaining mitochondrial homeostasis. Acta Pharmacol Sin. 2024;45:777\u201389.","journal-title":"Acta Pharmacol Sin."},{"key":"1793_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107261","volume":"206","author":"X Peng","year":"2024","unstructured":"Peng X, Ni H, Kuang B, Wang Z, Hou S, Gu S, et al. Sirtuin 3 in renal diseases and aging: from mechanisms to potential therapies. Pharmacol Res. 2024;206:107261.","journal-title":"Pharmacol Res"},{"key":"1793_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101151","volume":"63","author":"Y Fang","year":"2020","unstructured":"Fang Y, Gong AY, Haller ST, Dworkin LD, Liu Z, Gong R. The ageing kidney: molecular mechanisms and clinical implications. Ageing Res Rev. 2020;63:101151.","journal-title":"Ageing Res Rev"},{"key":"1793_CR13","doi-asserted-by":"crossref","unstructured":"Abekhoukh S, Bardoni B. CYFIP Family Proteins between Autism and Intellectual Disability: Links with Fragile X Syndrome. Front Cell Neurosci. 2014;8.","DOI":"10.3389\/fncel.2014.00081"},{"key":"1793_CR14","doi-asserted-by":"publisher","first-page":"8844","DOI":"10.1073\/pnas.151231598","volume":"98","author":"A Schenck","year":"2001","unstructured":"Schenck A, Bardoni B, Moro A, Bagni C, Mandel JL. A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P. Proc Natl Acad Sci USA. 2001;98:8844\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1793_CR15","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1080\/19768354.2019.1696406","volume":"23","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Kang HR, Han K. Differential cell-type-expression of CYFIP1 and CYFIP2 in the adult mouse hippocampus. Anim Cells Syst. 2019;23:380\u20133.","journal-title":"Anim Cells Syst"},{"key":"1793_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4161\/cc.6.1.3665","volume":"6","author":"RS Jackson II","year":"2007","unstructured":"Jackson II RS, Cho YJ, Stein S, Liang P. CYFIP2, a direct P53 target, is leptomycin-B sensitive. Cell Cycle. 2007;6:95\u2013103.","journal-title":"Cell Cycle"},{"key":"1793_CR17","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1093\/brain\/aww205","volume":"139","author":"SS Tiwari","year":"2016","unstructured":"Tiwari SS, Mizuno K, Ghosh A, Aziz W, Troakes C, Daoud J, et al. Alzheimer-related decrease in CYFIP2 links amyloid production to tau hyperphosphorylation and memory loss. Brain. 2016;139:2751\u201365.","journal-title":"Brain"},{"key":"1793_CR18","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1126\/science.1245503","volume":"342","author":"V Kumar","year":"2013","unstructured":"Kumar V, Kim K, Joseph C, Kourrich S, Yoo SH, Huang HC, et al. C57BL\/6N mutation in cytoplasmic FMRP interacting protein 2 regulates cocaine response. Science. 2013;342:1508\u201312.","journal-title":"Science"},{"key":"1793_CR19","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/ana.25208","volume":"83","author":"M Nakashima","year":"2018","unstructured":"Nakashima M, Kato M, Aoto K, Shiina M, Belal H, Mukaida S, et al. De novo hotspot variants in CYFIP2 cause early-onset epileptic encephalopathy. Ann Neurol. 2018;83:794\u2013806.","journal-title":"Ann Neurol"},{"key":"1793_CR20","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1093\/hmg\/ddu595","volume":"24","author":"K Han","year":"2015","unstructured":"Han K, Chen H, Gennarino VA, Richman R, Lu HC, Zoghbi HY. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice. Hum Mol Genet. 2015;24:1813\u201323.","journal-title":"Hum Mol Genet"},{"key":"1793_CR21","first-page":"1","volume":"2022","author":"S Fu","year":"2022","unstructured":"Fu S, Liu Y, Zhang Z, Mei M, Chen Q, Wang S, et al. Identification of a novel Myc-regulated gene signature for patients with kidney renal clear cell carcinoma. J Oncol. 2022;2022:1\u201321.","journal-title":"J Oncol"},{"key":"1793_CR22","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1161\/HYPERTENSIONAHA.120.16437","volume":"78","author":"JM Thomas","year":"2021","unstructured":"Thomas JM, Ling YH, Huuskes B, Jelinic M, Sharma P, Saini N, et al. IL-18 (Interleukin-18) produced by renal tubular epithelial cells promotes renal inflammation and injury during deoxycorticosterone\/salt-induced hypertension in mice. Hypertension. 2021;78:1296\u2013309.","journal-title":"Hypertension"},{"key":"1793_CR23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1793_CR24","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1042\/CS20240717","volume":"138","author":"Y Wei","year":"2024","unstructured":"Wei Y, Mou S, Yang Q, Liu F, Cooper ME, Chai Z. To target cellular senescence in diabetic kidney disease: the known and the unknown. Clin Sci. 2024;138:991\u20131007.","journal-title":"Clin Sci"},{"key":"1793_CR25","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ccell.2024.04.009","volume":"42","author":"Y Liu","year":"2024","unstructured":"Liu Y, Su Z, Tavana O, Gu W. Understanding the complexity of P53 in a new era of tumor suppression. Cancer Cell. 2024;42:946\u201367.","journal-title":"Cancer Cell"},{"key":"1793_CR26","first-page":"1206","volume":"44","author":"J Wu","year":"2023","unstructured":"Wu J, Wang X, Zhu J, Huang X, Liu M, Qiao Z, et al. GPR97 deficiency ameliorates renal interstitial fibrosis in mouse hypertensive nephropathy. Acta Pharmacol Sin. 2023;44:1206\u201316.","journal-title":"Pharmacol Sin"},{"key":"1793_CR27","doi-asserted-by":"crossref","unstructured":"Dey A. Targeting the hippo pathway in cancer, fibrosis, wound healing and regenerative medicine. Nat Rev Drug Discov. 2020;19:480\u201394.","DOI":"10.1038\/s41573-020-0070-z"},{"key":"1793_CR28","doi-asserted-by":"publisher","first-page":"897","DOI":"10.24272\/j.issn.2095-8137.2022.110","volume":"43","author":"C Zhang","year":"2022","unstructured":"Zhang C, Li CL, Xu KX, Zheng ZH, Cheng GZ, Wu HJ, et al. The hippo pathway and its correlation with acute kidney injury. Zool Res. 2022;43:897\u2013910.","journal-title":"Zool Res"},{"key":"1793_CR29","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41392-022-01191-9","volume":"7","author":"M Fu","year":"2022","unstructured":"Fu M, Hu Y, Lan T, Guan KL, Luo T, Luo M. The hippo signalling pathway and its implications in human health and diseases. Sig Transduct Target Ther. 2022;7:376.","journal-title":"Sig Transduct Target Ther"},{"key":"1793_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/cdd.2017.163","volume":"25","author":"N Furth","year":"2018","unstructured":"Furth N, Aylon Y, Oren M. P53 shades of hippo. Cell Death Differ. 2018;25:81\u201392.","journal-title":"Cell Death Differ"},{"key":"1793_CR31","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/HYPERTENSIONAHA.117.08314","volume":"70","author":"KA Griffin","year":"2017","unstructured":"Griffin KA. Hypertensive kidney injury and the progression of chronic kidney disease. Hypertension. 2017;70:687\u201394.","journal-title":"Hypertension"},{"key":"1793_CR32","doi-asserted-by":"crossref","unstructured":"Anandh U, Anders HJ, Bacchetta J, Johnson DW, Luyckx V, Remuzzi G, et al. Two decades of nephrology research: progress and future challenges. Nat Rev Nephrol. 2025;21:727\u201335.","DOI":"10.1038\/s41581-025-00996-5"},{"key":"1793_CR33","doi-asserted-by":"publisher","first-page":"6585","DOI":"10.3390\/ijms25126585","volume":"25","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Yu C, Li X. Kidney aging and chronic kidney disease. IJMS. 2024;25:6585.","journal-title":"IJMS"},{"key":"1793_CR34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s10522-024-10173-z","volume":"26","author":"K Goyal","year":"2025","unstructured":"Goyal K, Afzal M, Altamimi ASA, Babu MA, Ballal S, Kaur I, et al. Chronic kidney disease and aging: dissecting the P53\/P21 pathway as a therapeutic target. Biogerontology. 2025;26:32.","journal-title":"Biogerontology"},{"key":"1793_CR35","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1601-183X.2012.00768.x","volume":"11","author":"CA Hoeffer","year":"2012","unstructured":"Hoeffer CA, Sanchez E, Hagerman RJ, Mu Y, Nguyen DV, Wong H, et al. Altered mTOR signalling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome. Genes Brain Behav. 2012;11:332\u201341.","journal-title":"Genes Brain Behav"},{"key":"1793_CR36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1126\/science.aay5663","volume":"369","author":"SA Cook","year":"2020","unstructured":"Cook SA, Comrie WA, Poli MC, Similuk M, Oler AJ, Faruqi AJ, et al. HEM1 deficiency disrupts mTORC2 and F-Actin control in inherited immunodysregulatory disease. Science. 2020;369:202\u20137.","journal-title":"Science"},{"key":"1793_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47315-3","volume":"15","author":"L Li","year":"2024","unstructured":"Li L, Xiang T, Guo J, Guo F, Wu Y, Feng H, et al. Inhibition of ACSS2-mediated histone crotonylation alleviates kidney fibrosis via IL-1\u03b2-dependent macrophage activation and tubular cell senescence. Nat Commun. 2024;15:3200.","journal-title":"Nat Commun"},{"key":"1793_CR38","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/eji.200324726","volume":"34","author":"M Mayne","year":"2004","unstructured":"Mayne M, Moffatt T, Kong H, McLaren PJ, Fowke KR, Becker KG, et al. CYFIP2 is highly abundant in CD4+ cells from multiple sclerosis patients and is involved in T cell adhesion. Eur J Immunol. 2004;34:1217\u201327.","journal-title":"Eur J Immunol"},{"key":"1793_CR39","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.kint.2017.09.033","volume":"93","author":"BC Liu","year":"2018","unstructured":"Liu BC, Tang TT, Lv LL, Lan HY. Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int. 2018;93:568\u201379.","journal-title":"Kidney Int"},{"key":"1793_CR40","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1681\/ASN.0000000000000446","volume":"35","author":"X Liu","year":"2024","unstructured":"Liu X, Zhan P, Zhang Y, Jin H, Wang Y, Yang Y, et al. Lysosomal-associated protein transmembrane 5, tubular senescence, and progression of CKD. JASN. 2024;35:1655\u201370.","journal-title":"JASN"},{"key":"1793_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202402066","volume":"11","author":"H Xie","year":"2024","unstructured":"Xie H, Yang N, Lu L, Sun X, Li J, Wang X, et al. Uremic toxin receptor AhR facilitates renal senescence and fibrosis via suppressing mitochondrial biogenesis. Adv Sci. 2024;11:2402066.","journal-title":"Adv Sci"},{"key":"1793_CR42","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1681\/ASN.2017050574","volume":"29","author":"C Luo","year":"2018","unstructured":"Luo C, Zhou S, Zhou Z, Liu Y, Yang L, Liu J, et al. Wnt9a promotes renal fibrosis by accelerating cellular senescence in tubular epithelial cells. JASN. 2018;29:1238\u201356.","journal-title":"JASN"},{"key":"1793_CR43","doi-asserted-by":"publisher","first-page":"5248","DOI":"10.7150\/thno.54550","volume":"11","author":"JY Cao","year":"2021","unstructured":"Cao JY, Wang B, Tang TT, Wen Y, Li ZL, Feng ST, et al. Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of P53 in ischemic acute kidney injury. Theranostics. 2021;11:5248\u201366.","journal-title":"Theranostics"},{"key":"1793_CR44","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1681\/ASN.2020091373","volume":"32","author":"SR Kim","year":"2021","unstructured":"Kim SR, Puranik AS, Jiang K, Chen X, Zhu XY, Taylor I, et al. Progressive cellular senescence mediates renal dysfunction in ischemic nephropathy. JASN. 2021;32:1987\u20132004.","journal-title":"JASN"},{"key":"1793_CR45","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.166643","volume":"8","author":"S Li","year":"2023","unstructured":"Li S, Livingston MJ, Ma Z, Hu X, Wen L, Ding HF, et al. Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicity. JCI Insight. 2023;8:e166643.","journal-title":"JCI Insight"},{"key":"1793_CR46","doi-asserted-by":"publisher","first-page":"F122","DOI":"10.1152\/ajprenal.00489.2014","volume":"308","author":"J Megyesi","year":"2015","unstructured":"Megyesi J, Tarcsafalvi A, Li S, Hodeify R, Seng NSHL, Portilla D, et al. Increased expression of P21WAF1\/CIP1 in kidney proximal tubules mediates fibrosis. Am J Physiol-Ren Physiol. 2015;308:F122\u2013F130.","journal-title":"Am J Physiol-Ren Physiol"},{"key":"1793_CR47","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41580-018-0086-y","volume":"20","author":"IM Moya","year":"2019","unstructured":"Moya IM, Halder G. Hippo-YAP\/TAZ signalling in organ regeneration and regenerative medicine. Nat Rev Mol Cell Biol. 2019;20:211\u201326.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1793_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103649","volume":"28","author":"T Habshi","year":"2023","unstructured":"Habshi T, Shelke V, Kale A, Lech M, Gaikwad AB. Hippo signalling in acute kidney injury to chronic kidney disease transition: current understandings and future targets. Drug Discov Today. 2023;28:103649.","journal-title":"Drug Discov Today"},{"key":"1793_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11961","volume":"7","author":"DH Lee","year":"2016","unstructured":"Lee DH, Park JO, Kim TS, Kim SK, Kim T, Kim M, et al. LATS-YAP\/TAZ controls lineage specification by regulating TGF\u03b2 signalling and Hnf4\u03b1 expression during liver development. Nat Commun. 2016;7:11961.","journal-title":"Nat Commun"},{"key":"1793_CR50","doi-asserted-by":"publisher","first-page":"8184","DOI":"10.3390\/ijms21218184","volume":"21","author":"J Jin","year":"2020","unstructured":"Jin J, Wang T, Park W, Li W, Kim W, Park SK, et al. Inhibition of yes-associated protein by verteporfin ameliorates unilateral ureteral obstruction-induced renal tubulointerstitial inflammation and fibrosis. IJMS. 2020;21:8184.","journal-title":"IJMS"},{"key":"1793_CR51","doi-asserted-by":"publisher","first-page":"11109","DOI":"10.1096\/fj.201900325R","volume":"33","author":"DH Kim","year":"2019","unstructured":"Kim DH, Choi HI, Park JS, Kim CS, Bae EH, Ma SK, et al. Src-mediated crosstalk between FXR and YAP protects against renal fibrosis. FASEB J. 2019;33:11109\u201322.","journal-title":"FASEB J"},{"key":"1793_CR52","doi-asserted-by":"publisher","first-page":"9797","DOI":"10.1096\/fj.201802489RR","volume":"33","author":"S Patel","year":"2019","unstructured":"Patel S, Tang J, Overstreet JM, Anorga S, Lian F, Arnouk A, et al. Rac-GTPase promotes fibrotic TGF-\u03b21 signalling and chronic kidney disease via EGFR, P53, and Hippo\/YAP\/TAZ pathways. FASEB J. 2019;33:9797\u2013810.","journal-title":"FASEB J"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01793-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01793-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01793-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:04:49Z","timestamp":1787040289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01793-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1793"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01793-x","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}